Revenue was considerably weaker than expected in 3Q24, although positively the margin held up. We expect improving utilisation following recent awards to result in stronger earnings entering FY25. We maintain our SPEC BUY call on a $0.30 valuation.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.
